A client recovering from acute ischemic stroke with newly identified atrial fibrillation has CHA2DS2-VASc 5 and HAS-BLED 2. Which actions support secondary prevention? Select all that apply.
Select All That Apply
Choose your responses, then check the answer.
Explanation
Secondary prevention after stroke with AF: ANTICOAGULATION (DOAC preferred over warfarin in nonvalvular AF) when CHA2DS2-VASc indicates and HAS-BLED is acceptable; for cardioembolic AF stroke, anticoagulation is preferred over antiplatelet alone. Time to start depends on stroke size — small stroke 1-3 days, large 5-14 days post-event. High-intensity statin (atorvastatin 80, rosuvastatin 40) is standard. BP target generally under 130/80 with gradual lowering. OSA is a stroke risk factor — screen and treat. Indefinite DAPT alone is inferior in AF; antiplatelet plus anticoagulation increases bleeding without ischemic benefit unless specific indication (recent PCI).